Fundz

Genocea Biosciences, Inc. reported raising $12.1 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEFeb 27, 2019$12.1M of $15M raised

Amount Raised

$12.1 Million

$12.1 Million sold, per SEC Form D (first sale Feb 27, 2019)

Round Type

Venture

CambridgeBiotechnologyHealth CareTherapeuticsBiopharma

Quick answer

GENOCEA BIOSCIENCES, INC. raised $12.1 Million in a funding round, dated February 27, 2019. GENOCEA BIOSCIENCES, INC. is based in Cambridge, Massachusetts, United States.

How much did GENOCEA BIOSCIENCES, INC. raise?
GENOCEA BIOSCIENCES, INC. raised $12.1 Million in a funding round on February 27, 2019.
What does GENOCEA BIOSCIENCES, INC. do?
Genocea develops key breakthroughs in human vaccine discovery and development for antigens that induce T cell immunity.
Where is GENOCEA BIOSCIENCES, INC. based and how big is it?
GENOCEA BIOSCIENCES, INC. is based in Cambridge, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as GENOCEA BIOSCIENCES, INC. that raised within 45 days of this round, from Fundz verified event records.

  • Summit Therapeutics raised $25M on January 18, 2019.
  • Aura Biosciences, Inc. raised $20M on April 12, 2019.
  • Citius Pharmaceuticals, Inc. raised $429K (Seed) on April 8, 2019.
  • CytoDyn raised $3.2M (Seed) on April 2, 2019.
  • Enliven Therapeutics raised $44M on March 29, 2019.
  • Imago BioSciences, Inc. raised $17M on March 28, 2019.

Who to call at GENOCEA BIOSCIENCES, INC., and when

A new round usually means GENOCEA BIOSCIENCES, INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GENOCEA BIOSCIENCES, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GENOCEA BIOSCIENCES, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GENOCEA BIOSCIENCES, INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GENOCEA BIOSCIENCES, INC.

Location

100 ACORN PARK DRIVE

Cambridge, Massachusetts, United States

About

Genocea develops key breakthroughs in human vaccine discovery and development for antigens that induce T cell immunity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GENOCEA BIOSCIENCES, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for GENOCEA BIOSCIENCES, INC.'s next move

See what Strategic adds

GENOCEA BIOSCIENCES, INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.